LivsMed

491000 · KOSDAQ · ₩491000 · 리브스메드

₩39,400▼ ₩1,050 (2.60%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Filings

  • Investor relations (IR) event기업설명회(IR)개최Oct 1, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Oct 1, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 10, 2026Open on DART
  • Exercise of Stock Purchase Options주식매수선택권행사Jul 3, 2026Open on DART
  • [Amended Filing] Major Matters Report (Decision on Acquisition of Tangible Assets)[기재정정]주요사항보고서(유형자산양수결정)Jun 22, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • [Attached Correction] Material Matters Report (Decision on Acquisition of Tangible Assets)[첨부정정]주요사항보고서(유형자산양수결정)May 13, 2026Open on DART
  • Major Matters Report (Decision on Acquisition of Tangible Assets)주요사항보고서(유형자산양수결정)May 13, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 22, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 7, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 23, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 23, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 16, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Mar 10, 2026Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 27, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Feb 10, 2026Open on DART
  • [Amended] Exercise of Stock Purchase Options[기재정정]주식매수선택권행사Feb 4, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 28, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 28, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 28, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 28, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 28, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 28, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jan 28, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Jan 23, 2026Open on DART
  • Exercise of Stock Purchase Options주식매수선택권행사Jan 21, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Jan 16, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Jan 9, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 6, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 2, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 2, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jan 2, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Jan 2, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Dec 30, 2025Open on DART
  • Securities Issuance Results Report증권발행실적보고서Dec 18, 2025Open on DART
  • Amended: Prospectus[기재정정]투자설명서Dec 12, 2025Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Dec 12, 2025Open on DART
  • Prospectus투자설명서Dec 10, 2025Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Dec 5, 2025Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Nov 24, 2025Open on DART
  • Amended attachment: Securities registration statement[첨부정정]증권신고서(지분증권)Nov 18, 2025Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Nov 18, 2025Open on DART

Titles in Korean until English translations are added.

Also known as: LivsMed / 리브스메드 / 491000 / KRX:491000

Source: KRX statistical information